Harmonized System
U.S. imports of Ozone, Oxygen & Aerosol Therapy and Artificial Respiration Apparatus (HS 901920) totaled $391.7M in August 2026, imported from 51 countries.
Importers of Ozone, Oxygen & Aerosol Therapy and Artificial Respiration Apparatus paid $5.4M in duties in August 2026, an average duty rate of 1.39% — duty actually collected as a share of the imports that cleared customs, not the published tariff schedule.
Last updated: August 2026 dataRespiratory therapy equipment — including oxygen concentrators, CPAP/BiPAP devices, aerosol nebulizers, and artificial respiration apparatus — falls under this heading and is subject to FDA medical device regulation, with many life-sustaining devices requiring 510(k) clearance or premarket approval before US distribution. Singapore leads US imports under this heading, a reflection of the significant medical-device manufacturing base established there by multinational OEMs, with China and Mexico also supplying meaningful volumes. The heading consolidates into a single 10-digit tariff line (9019200000), so the classification question is typically whether a device performs therapeutic respiration versus merely delivering gas (which may fall elsewhere in Chapter 90 or under Chapter 84).
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
11.9K import shipments a month
The key distinction is therapeutic function: apparatus designed to treat a medical condition through ozone, oxygen, aerosol, or artificial respiration belongs here, while equipment that merely supplies or measures gas flow (e.g., industrial oxygen regulators) typically falls under Chapter 84 or other Chapter 90 headings. CBP binding rulings and the Explanatory Notes to heading 9019 are the primary reference points; a licensed customs broker can help assess borderline devices.
CPAP and BiPAP devices are Class II medical devices regulated by FDA's CDRH and generally require 510(k) premarket notification clearance. The foreign manufacturer must be registered with FDA and the device listed before importation. FDA may detain shipments at the port of entry if clearance documentation is not in order. Importers should work with a regulatory affairs specialist to confirm device classification and clearance status prior to shipment.
Subheading 1 of 2 in heading 9019
Subheading 901920 · $391.7M of $552.0M
Trade Directory
List your company under HS 901920 — Ozone, Oxygen & Aerosol Therapy and Artificial Respiration Apparatus, so the companies trading it can find you. Be the first supplier listed.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Imports for consumption | Average duty rate | Dutiable Share | Duty Collected |
|---|---|---|---|---|---|
| 9019200000 | Ozone, Oxygen, Etc Therapy, Respiration Apparatus, Pt | $391.6M | 1.39% | 12.27% | $5.4M |
Ozone, Oxygen, Etc Therapy, Respiration Apparatus, Pt
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 9019200000 | Ozone, Oxygen, Etc Therapy, Respiration Apparatus, Pt | $83.3M |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
Imports · August 2026
origin
Singapore and China together supply 56% of it.
customs district
destination
entry
rate provision · imports
87.7% enters free of duty; duty collected equals 1.39% of imports for consumption.
ImportsExports
Imports
$391.7MYoY · free account
Exports
$83.3MYoY · free account
12-mo low · imports
Low · free accountOver the twelve months to August 2026, the U.S. imported $4.4B of Ozone, Oxygen & Aerosol Therapy and Artificial Respiration Apparatus and exported $1.1B.
Through August 2026. Source: U.S. Census Bureau.